PP_1170x120_10-25-21

Alvogen

Alvogen to acquire four products from Pfizer

Alvogen to acquire four products from Pfizer

PINE BROOK, N.J. — Alvogen has entered an agreement to buy a portfolio of four U.S. pharmaceutical products from Pfizer Inc. Under the deal announced Wednesday, Alvogen plans to acquire three injectable products — Clindamycin, Voriconazole and Melphalan — and one inhaled solution product, Acetylcysteine. Financial terms of the deal weren’t disclosed. Two of the